- Home
- ANNX vs CYH Comparison
ANNX vs CYH Comparison
Compare ANNX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- CYH
- Stock Information
- Founded
- ANNX 2011
- CYH 1985
- Country
- ANNX United States
- CYH United States
- Employees
- ANNX N/A
- CYH N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- ANNX Health Care
- CYH Health Care
- Exchange
- ANNX Nasdaq
- CYH Nasdaq
- Market Cap
- ANNX 216.1M
- CYH 526.1M
- IPO Year
- ANNX 2020
- CYH 1991
- Fundamental
- Price
- ANNX $2.12
- CYH $3.84
- Analyst Decision
- ANNX Strong Buy
- CYH Hold
- Analyst Count
- ANNX 4
- CYH 8
- Target Price
- ANNX $12.50
- CYH $4.27
- AVG Volume (30 Days)
- ANNX 1.3M
- CYH 3.3M
- Earning Date
- ANNX 05-12-2025
- CYH 07-23-2025
- Dividend Yield
- ANNX N/A
- CYH N/A
- EPS Growth
- ANNX N/A
- CYH N/A
- EPS
- ANNX N/A
- CYH N/A
- Revenue
- ANNX N/A
- CYH $12,653,000,000.00
- Revenue This Year
- ANNX N/A
- CYH N/A
- Revenue Next Year
- ANNX N/A
- CYH $3.49
- P/E Ratio
- ANNX N/A
- CYH N/A
- Revenue Growth
- ANNX N/A
- CYH 1.05
- 52 Week Low
- ANNX $1.29
- CYH $2.24
- 52 Week High
- ANNX $7.85
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- ANNX 56.77
- CYH 59.76
- Support Level
- ANNX $1.92
- CYH $3.56
- Resistance Level
- ANNX $2.21
- CYH $3.96
- Average True Range (ATR)
- ANNX 0.17
- CYH 0.24
- MACD
- ANNX 0.03
- CYH -0.04
- Stochastic Oscillator
- ANNX 77.59
- CYH 30.77
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.